MYGN Financial Facts

Cost of companion diagnostic services: 3.38M
Earnings per basic share: 0.67
See Full Income Statement

Accrued liabilities: 45.84M
Accounts payable: 17.6M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 8/13/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +29.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/14 Q314 $0.48$0.45 +$0.03$176.2M$175.23M = Details
2/4/14 Q214 $0.66$0.46 +$0.20$204.06M$176.02M = Details
11/5/13 Q114 $0.68$0.46 +$0.22$202.47M$167.64M = Details
8/13/13 Q413 $0.53$0.44 +$0.09$174.1M$159.87M = Details
2/5/13 Q213 $0.42$0.38 +$0.04$149.1M$143.71M Details
5/7/13 Q113 $0.46$0.40 +$0.06$156.5M$148.25M Details
11/5/12 Q113 $0.36$0.32 +$0.04$133.44M$129.43M Details
1/31/12 Q212 $0.33$0.31 +$0.02$122.8M$115.28M = Details